<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3301211</article-id><article-id pub-id-type="publisher-id">cc5871</article-id><article-id pub-id-type="doi">10.1186/cc5871</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>A computer-guided insulin protocol causes less hypoglycemia than a strict glycemic control protocol: a randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Cavalcanti</surname><given-names>AB</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Eluf-Neto</surname><given-names>J</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Pereira</surname><given-names>AJ</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Caldeira</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Almeida</surname><given-names>FP</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Westphal</surname><given-names>G</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Beims</surname><given-names>R</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A8"><name><surname>Fernandes</surname><given-names>CC</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib><contrib contrib-type="author" id="A9"><name><surname>Correa</surname><given-names>TD</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A10"><name><surname>Gouvea</surname><given-names>MR</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A11"><name><surname>Silva</surname><given-names>E</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Hospital Israelita Albert Einstein, São Paulo – SP, Brazil</aff><aff id="I2"><label>2</label>University of São Paulo – SP, Brazil</aff><aff id="I3"><label>3</label>Hospital Dona Helena, Joinville – SC, Brazil</aff><aff id="I4"><label>4</label>Hospital Estadual Mario Covas, São Paulo – SP, Brazil</aff><pub-date pub-type="ppub"><year>2007</year></pub-date><pub-date pub-type="epub"><day>19</day><month>6</month><year>2007</year></pub-date><volume>11</volume><issue>Suppl 3</issue><supplement><named-content content-type="supplement-title">Fourth International Symposium on Intensive Care and Emergency Medicine for Latin America</named-content><ext-link ext-link-type="uri" xlink:href="http://ccforum.com/supplements/notes/ccv11s3-info.pdf">http://ccforum.com/supplements/notes/ccv11s3-info.pdf</ext-link></supplement><fpage>P84</fpage><lpage>P84</lpage><permissions><copyright-statement>Copyright ©2007 BioMed Central Ltd</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>BioMed Central Ltd</copyright-holder></permissions><self-uri xlink:href="http://ccforum.com/content/11/S3/P84"></self-uri><conference><conf-date>20-23 June 2007</conf-date><conf-name>Fourth International Symposium on Intensive Care and Emergency Medicine for Latin America</conf-name><conf-loc>São Paulo, Brazil</conf-loc></conference></article-meta></front><body><sec><title><offsets xml_i="4088" xml_f="4100" txt_i="7" txt_f="19">Introduction</offsets></title><p><offsets xml_i="4111" xml_f="4327" txt_i="20" txt_f="236">Strict glycemic control has been recommended for critically ill patients. However, its implementation may face difficulties with increased nursing workload, inadequate glucose control and higher risk of hypoglycemia.</offsets></p></sec><sec><title><offsets xml_i="4349" xml_f="4358" txt_i="238" txt_f="247">Objective</offsets></title><p><offsets xml_i="4369" xml_f="4519" txt_i="248" txt_f="398">We report the results of a randomized controlled trial to evaluate the efficacy and safety of three insulin algorithms in medical ICU (MICU) patients.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="4560" xml_f="4567" txt_i="400" txt_f="407">Methods</offsets></title><p><offsets xml_i="4578" xml_f="5299" txt_i="408" txt_f="1129">MICU patients with at least one blood glucose ≥150 mg/dl and who were on mechanical ventilation, or had SIRS, or were admitted because of trauma or burn were randomized to one of the following treatments: algorithm A – continuous insulin infusion with adjustments guided by a handheld device or desktop software targeting glucose levels between 100 and 130 mg/dl; algorithm B – continuous insulin aiming at glucose levels between 80 and 110 mg/dl; algorithm C – conventional treatment of intermittent subcutaneous administration of insulin if blood glucose levels exceeded 150 mg/dl. Efficacy was measured by the mean of patients' median blood glucose and safety was measured by the incidence of hypoglycemia (≤40 mg/dl).</offsets></p></sec><sec><title><offsets xml_i="5321" xml_f="5328" txt_i="1131" txt_f="1138">Results</offsets></title><p><offsets xml_i="5339" xml_f="5535" txt_i="1139" txt_f="1335">One hundred and nine patients were included. The APACHE II score was similar in the groups (20.5 ± 7.9). The efficacy and safety of the algorithms to attain glucose control are presented in Table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="5567" xml_f="5568" txt_i="1335" txt_f="1336">1</offsets></xref><offsets xml_i="5575" xml_f="5576" txt_i="1336" txt_f="1337">.</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="5624" xml_f="5631" txt_i="1338" txt_f="1345">Table 1</offsets></label><table frame="hsides" rules="groups"><thead><tr><th></th><th align="center"><offsets xml_i="5715" xml_f="5728" txt_i="1345" txt_f="1358">Algorithm A (</offsets><italic><offsets xml_i="5736" xml_f="5738" txt_i="1358" txt_f="1360">n </offsets></italic><offsets xml_i="5747" xml_f="5752" txt_i="1360" txt_f="1365">= 36)</offsets></th><th align="center"><offsets xml_i="5776" xml_f="5789" txt_i="1365" txt_f="1378">Algorithm B (</offsets><italic><offsets xml_i="5797" xml_f="5799" txt_i="1378" txt_f="1380">n </offsets></italic><offsets xml_i="5808" xml_f="5813" txt_i="1380" txt_f="1385">= 36)</offsets></th><th align="center"><offsets xml_i="5837" xml_f="5850" txt_i="1385" txt_f="1398">Algorithm C (</offsets><italic><offsets xml_i="5858" xml_f="5860" txt_i="1398" txt_f="1400">n </offsets></italic><offsets xml_i="5869" xml_f="5874" txt_i="1400" txt_f="1405">= 37)</offsets></th><th align="center"><italic><offsets xml_i="5906" xml_f="5908" txt_i="1405" txt_f="1407">P </offsets></italic><offsets xml_i="5917" xml_f="5927" txt_i="1407" txt_f="1417">all groups</offsets></th><th align="center"><italic><offsets xml_i="5959" xml_f="5961" txt_i="1417" txt_f="1419">P </offsets></italic><offsets xml_i="5970" xml_f="5976" txt_i="1419" txt_f="1425">A vs B</offsets></th></tr></thead><tbody><tr><td align="left"><offsets xml_i="6022" xml_f="6044" txt_i="1425" txt_f="1447">Glucose median (mg/dl)</offsets></td><td align="center"><offsets xml_i="6068" xml_f="6073" txt_i="1448" txt_f="1453">124.8</offsets></td><td align="center"><offsets xml_i="6097" xml_f="6102" txt_i="1454" txt_f="1459">128.5</offsets></td><td align="center"><offsets xml_i="6126" xml_f="6131" txt_i="1460" txt_f="1465">161.3</offsets></td><td align="center"><offsets xml_i="6155" xml_f="6164" txt_i="1466" txt_f="1472">&lt;0.001</offsets></td><td align="center"><offsets xml_i="6188" xml_f="6192" txt_i="1473" txt_f="1477">0.45</offsets></td></tr><tr><td align="left"><offsets xml_i="6223" xml_f="6237" txt_i="1478" txt_f="1492">Hypoglycemia (</offsets><italic><offsets xml_i="6245" xml_f="6247" txt_i="1492" txt_f="1494">n </offsets></italic><offsets xml_i="6256" xml_f="6260" txt_i="1494" txt_f="1498">(%))</offsets></td><td align="center"><offsets xml_i="6284" xml_f="6292" txt_i="1499" txt_f="1507">8 (22.2)</offsets></td><td align="center"><offsets xml_i="6316" xml_f="6325" txt_i="1508" txt_f="1517">17 (47.2)</offsets></td><td align="center"><offsets xml_i="6349" xml_f="6356" txt_i="1518" txt_f="1525">0 (0.0)</offsets></td><td align="center"><offsets xml_i="6380" xml_f="6389" txt_i="1526" txt_f="1532">&lt;0.001</offsets></td><td align="center"><offsets xml_i="6413" xml_f="6417" txt_i="1533" txt_f="1537">0.03</offsets></td></tr><tr><td align="left"><offsets xml_i="6448" xml_f="6460" txt_i="1538" txt_f="1550">MICU death (</offsets><italic><offsets xml_i="6468" xml_f="6470" txt_i="1550" txt_f="1552">n </offsets></italic><offsets xml_i="6479" xml_f="6483" txt_i="1552" txt_f="1556">(%))</offsets></td><td align="center"><offsets xml_i="6507" xml_f="6516" txt_i="1557" txt_f="1566">18 (51.4)</offsets></td><td align="center"><offsets xml_i="6540" xml_f="6549" txt_i="1567" txt_f="1576">19 (54.3)</offsets></td><td align="center"><offsets xml_i="6573" xml_f="6582" txt_i="1577" txt_f="1586">15 (40.5)</offsets></td><td align="center"><offsets xml_i="6606" xml_f="6610" txt_i="1587" txt_f="1591">0.47</offsets></td><td align="center"><offsets xml_i="6634" xml_f="6638" txt_i="1592" txt_f="1596">0.81</offsets></td></tr></tbody></table></table-wrap></sec><sec><title><offsets xml_i="6695" xml_f="6705" txt_i="1598" txt_f="1608">Conclusion</offsets></title><p><offsets xml_i="6716" xml_f="6959" txt_i="1609" txt_f="1852">A computer-guided insulin infusion protocol causes less episodes of hypoglycemia than, and is as efficacious as, the standard strict glycemic control protocol for controlling glucose at normal nonfasting levels (80–140 mg/dl) in MICU patients.</offsets></p></sec></body></article>